Organization Overview
Historical Acquisition Tree
Alternative names
lorcaserin (belviq) (2012 NDA)
Abdominal Pain (Phase 2)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Cardiovascular Diseases (Phase 3)
Cataplexy (Phase 1)
Cholangitis (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Connective Tissue Diseases (Phase 3)
Crohn Disease (Phase 2)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Diabetes Mellitus (Phase 3)
Eczema (Phase 2)
Eosinophilic Esophagitis (Phase 2)
Esophagitis (Phase 2)
Familial Primary Pulmonary Hypertension (Phase 3)
Hypertension (Phase 3)
Hypertension, Pulmonary (Phase 3)
Inflammatory Bowel Diseases (Phase 2)
Intestinal Diseases (Phase 2)
Irritable Bowel Syndrome (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Liver Diseases (Phase 1)
Lung Diseases (Phase 3)
Narcolepsy (Phase 1)
Obesity (Phase 3)
Overweight (Phase 3)
Pyoderma (Phase 2)
Pyoderma Gangrenosum (Phase 2)
Renal Insufficiency (Phase 1)
Respiratory Tract Diseases (Phase 3)
Substance-Related Disorders (Phase 1)
Syndrome (Phase 2)
Ulcer (Phase 3)
Vascular Diseases (Phase 3)